×

Methods for treating patients who are candidates for inhaled nitric oxide treatment

DC CAFC
  • US 8,795,741 B2
  • Filed: 11/21/2012
  • Issued: 08/05/2014
  • Est. Priority Date: 06/30/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating patients who are candidates for inhaled nitric oxide treatment, which method reduces the risk that inhalation of nitric oxide gas will induce an increase in pulmonary capillary wedge pressure (PCWP) leading to pulmonary edema in neonatal patients with hypoxic respiratory failure, the method comprising:

  • (a) identifying a plurality of term or near-term neonatal patients who have hypoxic respiratory failure and are candidates for 20 ppm inhaled nitric oxide treatment;

    (b) determining that a first patient of the plurality does not have left ventricular dysfunction;

    (c) determining that a second patient of the plurality has left ventricular dysfunction, so is at particular risk of increased PCWP leading to pulmonary edema upon treatment with inhaled nitric oxide;

    (d) administering 20 ppm inhaled nitric oxide treatment to the first patient; and

    (e) excluding the second patient from treatment with inhaled nitric oxide, based on the determination that the second patient has left ventricular dysfunction, so is at particular risk of increased PCWP leading to pulmonary edema upon treatment with inhaled nitric oxide.

View all claims
  • 29 Assignments
Timeline View
Assignment View
    ×
    ×